UBS Group »

Ionis Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Ionis Pharmaceuticals shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1k 1.0k 1.05

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Ionis Pharmaceuticals

Steelhead Partners
Citadel Advisors
Lazard Asset Management
Tenor Capital Management
CSS
MacKay Shields
Capstone Investment Advisors
Wolverine Asset Management
Wells Fargo & Company
DeepCurrents Investment Group
Calamos Advisors
Bnp Paribas Arbitrage, Snc
Aviva
Shenkman Capital Management
Deutsche Bank Aktiengesellschaft

View all funds holding Ionis Pharmaceuticals